Gilead Sciences, Inc. today announced data from a two-and-a-half-year interim analysis from the ongoing Phase 3 ASSURE study, which showed that 81% (30 out of 37) of participants with primary biliary ...

M3 ( (MTHRF) ) has released its Q2 earnings. Here is a breakdown of the information M3 presented to its investors. M3 Inc. is a Tokyo-based ...

A judge has set a July trial date for a man facing the death penalty in a daylong shooting rampage in Memphis, Tennessee.

Trace Neuroscience, which launched this week with $101 million, benefited from last year’s approval of Qalsody. Its CEO spoke ...

Revenues in the fiscal second quarter of 2025 decreased 3% to $201,000, largely due to decreased sales to veterinary clinics. The decrease was partially offset by a 24% increase in sales to ...